Atypical antipsychotics in bipolar disorder: The treatment of mania

Advances in Psychiatric Treatment

Volumn 14, Issue 5, 2008, Pages 330-338

  Cookson, John ^a,b  

^a EAST LONDON NHS FOUNDATION TRUST   (United Kingdom)

^b Mile End Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; CARBAMAZEPINE; HALOPERIDOL; LITHIUM SALT; LORAZEPAM; NEUROLEPTIC AGENT; OLANZAPINE; PLACEBO; QUETIAPINE; RISPERIDONE; TAMOXIFEN; VALPROIC ACID; ZIPRASIDONE;

AKATHISIA; ARTICLE; BIPOLAR DISORDER; CLINICAL PRACTICE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DEPRESSION; DIZZINESS; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; EXTRAPYRAMIDAL SYMPTOM; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERKINESIA; INCREASED APPETITE; MANIA; METABOLIC DISORDER; MONOTHERAPY; NAUSEA; NOSE DISEASE; RHINORRHEA; RUNNING NOSE; SIDE EFFECT; SOMNOLENCE; TREATMENT DURATION; WEAKNESS; WEIGHT GAIN; XEROSTOMIA;

EID: 58049111950     PISSN: 13555146     EISSN: None     Source Type: Journal    
DOI: 10.1192/apt.bp.107.004150     Document Type: Article

References (55)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). APA.
2. Baker, R. W., Tohen, M., Fawcett, J., et al (2003) Acute dysphoric mania: treatment response to olanzapine versus placebo. Journal of Clinical Psychopharmacology, 23, 132-137.
3. Baker, R. W., Brown, E., Akiskal, H. S., et al (2004) Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania. British Journal ofPsychiatry, 185, 472-478.
4. Bowden, C. L., Brugger, A. M., Swann, A. C., et al (1994) Efficacy of divalproex v. lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA, 271, 918-924.
5. Bowden, C. L., Grunze, H., Mullen, J., et al (2005) A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. Journal of Clinical Psychiatry, 66, 111-121.
6. Chou, J. C., Zito, J. M., Vitrai, J., et al (1996) Neuroleptics in acute mania: a pharmacoepidemiologic study. Annals of Pharmacotherapy, 30, 1396-1398.
7. Cookson, J. C. (2001) Use of antipsychotic drugs and lithium in mania. British Journal of Psychiatry, 178 (suppl. 41), s148-s156.
8. Cookson, J. C. (2005) Treatment of mania. In Handbook of Affective Disorders: Diagnosis and Therapeutic Approaches (eds S. Kasper & R. Hirschfeld), pp. 157-178. Taylor & Francis.
9. Cookson, J. C. (2006) Haloperidol and risperidone in mania. In Bipolar Psychopharmacotherapy: Caring for the Patient (eds H. S. Akiskal & M. Tohen), pp. 105-124. John Wiley & Sons.
10. Cookson, J. C. (2007) Mania, bipolar disorder and their treatment. In Seminars in General Adult Psychiatry (2nd edn) (eds G. Stein & G. Wilkinson), pp. 22-47. Gaskell.
11. Cookson, J. C. & Ghalib, S. (2005) The treatment of bipolar mixed states. In Bipolar Disorder: Mixed States, Rapid Cycling and Atypical Forms (eds A. Marneros & F. Goodwin), pp. 324-352. Cambridge University Press.
12. Cookson, J. C., Silverstone, T. & Wells, B. (1981) A double-blind comparative clinical trial of pimozide and chlorpromazine in mania: a test of the dopamine hypothesis. Acta Psychiatrica Scandinavica, 64, 381-397.
13. Cookson, J. C., Taylor, D. & Katona, C. (2002) Placebo effects, evaluating evidence, and combining psychotherapy. In Use of Drugs in Psychiatry: The Evidence ftoin Psychopharmacology, pp. 117-131. Gaskell.
14. Del Bello, M. P., Kowatch, R. A., Alder C. M., et al (2006) A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 305-313.
15. Endicott, J. & Spitzer, R. L. (1978) A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Archives of General Psychiatry, 35, 837-844.
16. Goldsmith, D. R., Wagstaff, A. J., Ibbotson, T., et al (2003) Lamotrigine: a review of its use in bipolar disorder. Drugs, 63, 2029-2205.
17. Hirschfeld, R. M. A., Allen, M. H., McEvoy, J. P., et al (1999) Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients. Journal of Clinical Psychiatry, 60, 815-818.
18. Hirschfeld, R., Keck, P. E., Karcher, K., et al (2004) Rapid antimanic effect of risperidone monotherapy: a 3-week multicentre, double-blind, placebo-controlled trial. American Journal of Psychiatry, 161, 1057-1065.
19. Keck, P. E., Marcus, R., Tourkodimitris, S., et al (2003a) A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute mania. American Journal of Psychiatry, 160, 1651-1658.
20. Keck, P. E. Jr., Versiani, M., Potkin, S., et al (2003b) Ziprasidone in the treatrnent of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. American Journal of Psychiatry, 160, 741-748.
21. Khanna, S., Vieta, E., Lyons, B., (2005) Risperidone in the treatment of acute mania: double-blind, placebo-controlled study. British Journal of Psychiatry, 187, 229-234.
22. Klein, E., Bental, E., Lerer B., et al (1984) Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses. A controlled study. Archives of General Psychiatry, 41, 165-170.
23. McElroy, S. L., Keck, P. E. Jr, Stanton, S. P., et al (1996) A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. Journal of Clinical Psychiatry, 57, 142-146.
24. McIntyre, R. S., Brecher, M., Paulsson, B., et al (2005) Quetiapine or haloperidol as monotherapy for bipolar mania: a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial. European Neuropsychopharmacology, 15, 573-585.
25. Meehan, K., Zhang, F., David, S., et al (2001) A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania. Journal of Clinical Psychopharmacology, 21, 389-397.
26. Moller, H. J., Kissling, W., Riehl, T., et al (1989) Double-blind evaluation of the antimanic properties of carbamazepine as a comedication to haloperidol. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 13, 127-136.
27. Muller-Oerlinghausen, B., Retzow, A., Henn, F. A., et al (2000) Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicentre study. Journal of Clinical Psychopharmacology, 20, 195-203.
28. National Collaborating Centre for Mental Health (2006) Guideline 38: Management of Bipolar Disorder in Adults, Children and Adolescents, in Primary and Secondary Care. National Institute for Health and Clinical Excellence.
29. Peroutka, S. J. & Snyder, S. H. (1980) Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency. American Journal of Psychiatry, 137, 1518-1522.
30. Phrolov, K., Applebaum, J., Levine, J., et al (2004) Single dose intravenous valproate in acute mania. Journal of Clinical Psychiatry, 65, 68-70.
31. Pope, H. G., McElroy, S. L., Keck, P. E., et al (1991) Valproate in the treatment of acute mania: a placebo-controlled study. Archives of General Psychiatry, 48, 62-68.
32. Potkin, S. G., Keck, R E. Jr., Segal, S., et al (2005) Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial. Journal of Clinical Psychopharmacology, 25, 301-310.
33. Rifkin, A., Doddi, S., Karajgi, B., et al (1994) Dosage of haloperidol for mania. British Journal of Psychiatry, 165, 113-116.
34. Sachs, G. S., Sanchez, R., Marcus, R. N. et al, (2006) Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study. Journal of Psychopharmacology, 20, 536-546.
35. Scherk, H., Pajonk, F. G. & Leucht, S. (2007) Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials. Archives of General Psychiatry, 64, 442-455.
36. Segal, J., Berk, M. & Brook, S. (1998) Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clinical Neuropharmacology, 21, 176-180.
37. Smulevich, A. B., Khanna, S., Eerdekens, M., et al (2005) Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol. European Neuropsychopharmacology, 15, 75-84.
38. Suppes, T., Webb, A., Paul, B., et al (1999) Clinical outcome in a randomised 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. American Journal of Psychiatry, 156, 1164-1169.
39. Tohen, M., Sanger, T. M., McElroy, S. L., et al (1999) Olanzapine versus placebo in the treatment of acute mania. American Journal of Psychiatry, 156, 702-709.
40. Tohen, M., Jacobs, T. G., Grundy, S. L., et al (2000) Efficacy of olanzapine in acute bipolar mania: a double-blind, placebocontrolled study. Archives of General Psychiatry, 57, 841-849.
41. Tohen, M., Baker, R. W., Altshuler, L. L., et al (2002) Olanzapine versus divalproex in the treatment of acute mania. American Journal of Psychiatry, 159, 1011-1017.
42. Tohen, M., Goldberg, J. F., Gonzalez-Pinto, A. M., et al (2003) A 12-week double-blind comparison of olanzapine versus haloperidol in the treatment of acute mania. Archives of General Psychiatry, 60, 1218-1226.
43. Tohen, M., Kryzhanovskaya, L., Carlson, G., et al (2007) Olanzapine versus placebo in the treatment of adolescents with bipolar mania. American Journal of Psychiatry, 164, 547-1556.
44. Tohen, M., Bowden, C. L., Smulevich, A. B., et al (2008) Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes. British Journal of Psychiatry, 192, 135-143.
45. Vieta, E., Mullen, J., Brecher, M., et al (2005) Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebocontrolled studies. Current Medical Research and Opinion, 21, 923-934.
46. van Putten, T. & May, R. P. (1978) "Akinetic depression" in schizophrenia. Archives of General Psychiatry, 35, 1101-1107.
47. Weisler, R. H., Kalali, A. H., Ketter, T. A., et al (2004) A multicentre, randomised, double-blind, placebo-controlled of extendedrelease carbamazepine capsules as monotherapy in bipolar disorder patients with manic or mixed episodes. Journal of Clinical Psychiatry, 65, 478-484.
48. Weisler, R. H., Keck, P. E., Swann, A. C., et al (2005) Extendedrelease carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multi-centre, randomised, doubleblind, placebo-controlled trial. Journal of Clinical Psychiatry, 66, 323-330.
49. Yatham, L. N., Grossman, F., Augustyns, I., et al (2003) Mood stabilisers plus risperidone or placebo Mood stabilisers plus risperidone or placebo in the treatment of acute mania in the treatment of acute mania: international, double-blind, randomised controlled trial. British Journal of Psychiatry, 182, 141-147.
50. Yildiz, A., Guleryuz, S., Ankerst, D. P., et al (2008) Protein kinase C inhibition in the treatment of mania: a double-blind, placebocontrolled trial of tamoxifen. Archives of General Psychiatry, 65, 255-263.
51. Young, R. C., Biggs, J. T., Ziegler, V. E., et al (1978) A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry, 133, 429-435.
52. Zajecka, J. M., Weisler, R., Sachs, G., et al (2002) A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder. Journal of Clinical Psychiatry, 63, 1148-1155.
53. Zarate, C. A. & Tohen, M. (2004) Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients. American Journal of Psychiatry, 161, 169-171.
54. Zarate Jr, C. A., Singh, J. B., Carlson, P. J., et al (2007) Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study. Bipolar Disorders, 9, 561-570.
55. Zimbroff, D. L., Marcus, R. N., Manos, G., et al (2007) Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole. Journal of Clinical Psychopharmacology, 27, 171-176.